Pfizer Inc. v. United States, No. 17-2307 (2d Cir. 2019)Annotate this Case
The Second Circuit vacated the district court's dismissal of Pfizer's claim against the United States for overpayment interest on its delayed tax refund. The court held that jurisdiction of Pfizer's claim for overpayment lies exclusively with the United States Court of Federal Claims. The court explained that overpayment interest is a straightforward claim against the federal government that was covered by the Tucker Act. Accordingly, the court transferred the case to the Court of Federal Claims.